International Clinical Trial: Prospective Randomized Controlled Trial of Radiofrequency Ablation versus Stereotactic Body Radiotherapy for Inoperable Stage IA Non-Small Cell Lung Cancer

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128457) titled 'Prospective Randomized Controlled Trial of Radiofrequency Ablation versus Stereotactic Body Radiotherapy for Inoperable Stage IA Non-Small Cell Lung Cancer' on July 21.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Cancer Hospital Chinese Academy of Medical Sciences

Condition: stage IA non-small cell lung cancer

Intervention: Radiofrequency Ablation Group:Radiofrequency Ablation(RFA)

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-12-24

Target Sample Size: Radiofrequency Ablation Group:138;Stereotactic Body Radiotherapy Group:138;

Countries of Rec...